D. Stroncek

发表

Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome

D. Stroncek, A. Hubel, C. Whitley, 1999, Transfusion.

Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II.

C. Whitley, D. Stroncek, R. Shankar, 1999, Human gene therapy.

Retroviral transduction of peripheral blood leukocytes in a hollow‐ fiber bioreactor

D. Stroncek, C. Whitley, D. Stroncek, 1997, Transfusion.

Adverse reactions in patients transfused with cryopreserved marrow

D. Stroncek, J. McCullough, S. Fautsch, 1991, Transfusion.

Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).

R. Latchaw, R. McIvor, B. Blazar, 1996, Human gene therapy.

Results of bone marrow transplants from unrelated donors

D. Stroncek, 1992, Transfusion.

Psychosocial effects of unrelated bone marrow donation: experiences of the National Marrow Donor Program

D. Stroncek, R. Simmons, G. Bartsch, 1993 .

Psychosocial effects of unrelated bone marrow donation: experiences of the National Marrow Donor Program.

D. Stroncek, R. Simmons, G. Bartsch, 1993, Blood.

The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort

T. Fleisher, S. Leitman, D. Stroncek, 2011, Transfusion.

Blood counts in healthy donors 1 year after the collection of granulocyte–colony‐stimulating factor‐mobilized progenitor cells and the results of a second mobilization and collection

D. Stroncek, J. McCullough, S. Ilstrup, 1997, Transfusion.

Peripheral blood progenitor cells for HPC transplants involving unrelated donors

S. Leitman, D. Confer, D. Stroncek, 2000, Transfusion.

Granulocyte transfusions: a review

S. Leitman, D. Stroncek, David F. Stroncek, 1998, Immunohematology.

The National Marrow Donor Program: how it works, accomplishments to date.

H. Perkins, J. Hansen, J. McCullough, 1989, Oncology.

Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

D. Stroncek, D. Stroncek, J. McCullough, 1996, Transfusion.

Mobilization and transduction of peripheral blood progenitor cells in patients with mucopolysaccharidosis I.

A. Hubel, C. Whitley, D. Stroncek, 1998, Journal of hematotherapy.

Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.

P V Holland, J. Hansen, P. Holland, 1993, Blood.

Prolonged neutropenia resulting from antibodies to neutrophil‐specific antigen NB1 following marrow transplantation

D. Stroncek, M. Clay, R. Shapiro, 1993, Transfusion.

Granulocyte immunology: is there a need to know?

D. Stroncek, 1997, Transfusion.

Posttransfusion purpura following bone marrow transplantation

C. Verfaillie, D. Stroncek, J. Radford, 1995, Transfusion.

Effects on donors of second bone marrow collections

N. Ramsay, P. Mcglave, D. Stroncek, 1991, Transfusion.

The National Marrow Donor Program

J. Hansen, J. McCullough, D. Stroncek, 1993, Transfusion.

Selection of platelets for refractory patients by HLA matching and prospective crossmatching

J. Rowe, M. Saleh, D. Stroncek, 1992, Transfusion.

Comparison of two blood cell separators in collecting peripheral blood stem cell components

D. Stroncek, J. McCullough, W. Jaszcz, 1997, Transfusion medicine.

Polyclonal antibodies against the NB1‐bearing 58‐ to 64‐kDa glycoprotein of human neutrophils do not identify an NB2‐bearing molecule

A. Dalmasso, D. Stroncek, R. Shankar, 1993, Transfusion.

Polyclonal antibodies against the NBZ-bearing

A. Dalmasso, D. Stroncek, R. Shankar, 2009 .

Attitudes and physical condition of unrelated bone marrow donors immediately after donation

E. Scott, J. McCullough, D. Stroncek, 1989, Transfusion.

The changing activities of a regional marrow donor program

D. Stroncek, J. McCullough, R. Strand, 1994, Transfusion.

Bone marrow donor registries and international cooperation.

D. Stroncek, N. Buskard, 1993, Transfusion medicine reviews.

Idiopathic thrombocytopenia and neutropenia in childhood.

J. Freedman, A. Zipursky, D. Stroncek, 1994, The American journal of pediatric hematology/oncology.

Determination of ABO glycosyltransferase genotypes by use of polymerase chain reaction and restriction enzymes

D. Stroncek, J. McCullough, J. P. Houchins, 1995, Transfusion.

Changes in blood counts after the administration of granulocyte‐colony‐ stimulating factor and the collection of peripheral blood stem cells from healthy donors

D. Stroncek, D. Stroncek, J. McCullough, 1996, Transfusion.

Expression of neutrophil antigens after 10 days of granulocyte‐colony‐stimulating factor

D. Stroncek, D. Stroncek, J. McCullough, 1998, Transfusion.

The chemical and immunoglobulin structural features necessary for reactions of quinine‐dependent antibodies to neutrophils

D. Stroncek, D. Stroncek, G. Herr, 1995, Transfusion.

The kinetics of G‐CSF mobilization of CD34+ cells in healthy people

D. Stroncek, D. Stroncek, J. McCullough, 1997, Transfusion medicine.

Chloramphenicol‐dependent antibody: a case report

D. Stroncek, M. Fried, D. F. Stroncek, 1996, Transfusion.

Composition of peripheral blood progenitor cell components collected from healthy donors

D. Stroncek, D. Stroncek, J. McCullough, 1997, Transfusion.

Characterization of the neutrophil molecules identified by quinine‐ dependent antibodies from two patients

D. Stroncek, L. Clement, G. Herr, 1994, Transfusion.

Concentration of citrate anticoagulant in peripheral blood progenitor cell collections

D. Stroncek, D. Stroncek, S. Burger, 1996, Transfusion.

Autoimmune neutropenia in Sheboygan County, Wisconsin.

D. Stroncek, P. Beatty, 1992, Journal of Laboratory and Clinical Medicine.

Identification of a new white cell antigen

G. Ramsey, D F Stroncek, G Ramsey, 1994, Transfusion.

Serologic evidence that factor IX inhibitor in the plasma of hemophilia B patients detects factor IX on normal red cells

C. Moertel, D. Stroncek, N. Key, 1996, Transfusion.